Citation Impact
Citing Papers
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
2009
Inhibition of Growth and Metastasis of Human Pancreatic Cancer Growing in Nude Mice by PTK 787/ZK222584, an Inhibitor of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinases
2001
Guidelines for the welfare and use of animals in cancer research
2010 Standout
A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2007 StandoutNobel
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 Standout
Hyaluronic Acid Hydrogels for Biomedical Applications
2011 Standout
Src activation of Stat3 is an independent requirement from NF-κB activation for constitutive IL-8 expression in human pancreatic adenocarcinoma cells
2006
Atopic Dermatitis
2008 Standout
Synthetic Extracellular Matrix Enhances Tumor Growth and Metastasis in an Orthotopic Mouse Model of Pancreatic Adenocarcinoma
2007
Trial of oral miltefosine for visceral leishmaniasis
1998
Innate immune sensing and its roots: the story of endotoxin
2003 StandoutNobel
Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection
2003 Standout
HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas
2005 StandoutNobel
Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties
2003
The immunogenetics of asthma and eczema: a new focus on the epithelium
2004
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
EMT and Dissemination Precede Pancreatic Tumor Formation
2012 Standout
The genetics of psoriasis, psoriatic arthritis and atopic dermatitis
2004
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
2015 StandoutNature
Juvenile idiopathic arthritis
2007 Standout
Distinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer
2007 Standout
Riboflavin as a Source of Autofluorescence in Eisenia fetida Coelomocytes
2006
Synovial fibroblasts spread rheumatoid arthritis to unaffected joints
2009
Biodegradable polymer-based interleukin-12 gene delivery: role of induced cytokines, tumor infiltrating cells and nitric oxide in anti-tumor activity
2002
Losartan Slows Pancreatic Tumor Progression and Extends Survival of SPARC-Null Mice by Abrogating Aberrant TGFβ Activation
2012
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Infliximab Reduces the Cytokine-Mediated Inflammation but Does Not Suppress Cellular Infiltration of the Vessel Wall in Refractory Kawasaki Disease
2009
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Platelet Activation and Atherothrombosis
2007 Standout
Regulation of Hypoxia-Inducible Factor-1α, Vascular Endothelial Growth Factor, and Angiogenesis by an Insulin-Like Growth Factor-I Receptor Autocrine Loop in Human Pancreatic Cancer
2003 StandoutNobel
Toll-like receptor signalling
2004 Standout
CD36 is a sensor of diacylglycerides
2005 StandoutNatureNobel
The development of allergic inflammation
2008 StandoutNature
Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9)
1998
Extracellular Metabolic Energetics Can Promote Cancer Progression
2015
Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron
2004 StandoutNature
Pancreas Microenvironment Promotes VEGF Expression and Tumor Growth: Novel Window Models for Pancreatic Tumor Angiogenesis and Microcirculation
2001
Emerging Biological Principles of Metastasis
2017 Standout
Macrophage stimulation with Murabutide, an HIV-suppressive muramyl peptide derivative, selectively activates extracellular signal-regulated kinases 1 and 2, C / EBPβ and STAT1: role of CD14 and Toll-like receptors 2 and 4
2001
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
TGFβ in Cancer
2008 Standout
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
A potential role of macrophage activation in the treatment of cancer
2002
Rheumatoid arthritis
2010 Standout
Addicted to Death
2004
Sensitization of pancreatic cancer cells to radiation by cerium oxide nanoparticle-induced ROS production
2012
Signaling by IL‐12 and IL‐23 and the immunoregulatory roles of STAT4
2004
Pancreatic Cancer
2010 Standout
Identification of Lps2 as a key transducer of MyD88-independent TIR signalling
2003 StandoutNatureNobel
Proinflammatory S100 proteins in arthritis and autoimmune disease
2004
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles
2001 Standout
Effect of the vascular endothelial growth factor receptor‐2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice
2002
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Exploring the full spectrum of macrophage activation
2008 Standout
Macrophages direct tumour histology and clinical outcome in a colon cancer model
2005
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Pathogen Recognition and Innate Immunity
2006 Standout
Leishmaniasis
1999 Standout
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
2006 Standout
Toll-Like Receptors
2003 Standout
Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma.
2000
Cutting Edge: Role of Toll-Like Receptor 1 in Mediating Immune Response to Microbial Lipoproteins
2002 Standout
Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.
2000
Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer.
2002
Nonviral Vectors for Gene Delivery
2008 Standout
Fluorescence Lifetime Measurements and Biological Imaging
2010 Standout
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model.
2002
Breast cancer during pregnancy.
2001
Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor:In vivoexpression and antitumor activity
2000
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular Events
2006
Blockade of the epidermal growth factor receptor signaling inhibits angiogenesis leading to regression of human renal cell carcinoma growing orthotopically in nude mice.
2002
Imaging Tri-Fusion Multimodality Reporter Gene Expression in Living Subjects
2004 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Blockade of Transforming Growth Factor-β Signaling Suppresses Progression of Androgen-Independent Human Prostate Cancer in Nude Mice
2005
Gemcitabine Selectively Eliminates Splenic Gr-1+/CD11b+ Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity
2005
GENETIC ANALYSIS OF HOST RESISTANCE: Toll-Like Receptor Signaling and Immunity at Large
2006 StandoutNobel
S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules
2006
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Works of Ines Eue being referenced
In Vivo Selection and Characterization of Metastatic Variants from Human Pancreatic Adenocarcinoma by Using Orthotopic Implantation in Nude Mice
1999
High-resistance MDCK-C7 monolayers used for measuring invasive potency of tumour cells
2000
Growth inhibition of human mammary carcinoma by liposomal hexadecylphosphocholine: Participation of activated macrophages in the antitumor mechanism
2001
Evidence for perforin-like activity associated with earthworm leukocytes
2001
Transendothelial migration of 27E10+ human monocytes
2000
The Transcription Factors c-myb and C/EBPα Regulate the Monocytic/Myeloic Gene MRP14
1998
Influence of hexadecylphosphocholine on the release of tumor necrosis factor and nitroxide from peritoneal macrophages in vitro
1995
Suppression of tumorigenicity and metastasis in murine UV-2237 fibrosarcoma cells by infection with a retroviral vector harboring the interferon-beta gene
1998
S100A8, S100A9 and the S100A8/A9 heterodimer complex specifically bind to human endothelial cells: identification and characterization of ligands for the myeloid-related proteins S100A9 and S100A8/A9 on human dermal microvascular endothelial cell line-1 cells
2002
Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta.
1999
Activation of cytokine production, tumoricidal properties, and tyrosine phosphorylation of MAPKs in human monocytes by a new synthetic lipopeptide, JBT3002
1998